MAIA Biotechnology Stock Plummets After Heavily Discounted $30 Million Share Sale
MAIA Biotechnology saw its shares slide sharply in premarket trading after disclosing a $30 million public offering priced at a deep discount. The company sold 20 million new shares at $1.50 apiece, a 27.5% markdown from the previous close, and said proceeds will be applied to clinical trials and general corporate needs. The offering was led by hea…